How a new antibiotic destroys extremely drug-resistant tuberculosis | Ars Technicahttps://arstechnica.com/science/2019/08/how-a-new-antibiotic-destroys-extremely-drug-resistant-tuberculosis/
2019-08 FDA approves Pretomanid Tablets in combination with bedaquiline and linezolid for treatment of XDR-TBAmikacinCapreomycinGram-negative bacteriaKanamycinLevofloxacinLinezolidPretomanidTB Alliance
Mumbai pharma company gets licence for breakthrough TB drug | India News - Times of Indiahttps://timesofindia.indiatimes.com/india/mumbai-pharma-company-gets-licence-for-breakthrough-tb-drug/articleshow/71787870.cms
Bedaquiline-linezolid-pretomanid (BPaL)Extensively drug-resistant tuberculosis (XDR-TB)PretomanidTB Alliance
Stewardship / Resistance Scan for Oct 28, 2019 | CIDRAPhttp://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-28-2019
Bacterial pneumoniaBedaquiline-linezolid-pretomanid (BPaL)DelafloxacinMoxifloxacinNDM-1OXA-48TB Alliance

Showing topic

TB Alliance
Tuberculosis